arrow
S

Suwat Chariyalertsak

Chiang Mai University
H指数:43
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age- and sex-specific reference values for plasma lipids and lipoproteins in thai adults: a national health examination survey analysis

泰国成年人血浆脂质和脂蛋白的年龄和性别特定参考值:一项全国健康检查调查分析

2025-12-111
PRE
Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

HPTN 083研究中男男性行为者(MSM)和跨性别女性(TGW)中预防有效的CAB-LA浓度估算

2025-11-010
PRE
Vaccine Induced Seroreactivity Following Administration of ALVAC-HIV/AIDSVAX®B/E Identified by Common Anti-HIV Test Kits and Algorithms in Thailand

在泰国,通过常用抗-HIV检测试剂盒和算法鉴定,接种ALVAC-HIV/AIDSVAX®B/E疫苗后引发的血清反应性。

2025-10-010
PRE
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production
2024-02-130
OAAI
A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)

年轻的性和性别少数民族对三种直肠杀菌剂安慰剂制剂的依从性的潜在轨迹分析 (MTN-035; 随机交叉试验)

2023-12-080
OAAI
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
2023-05-083
OA
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

对接受可注射卡博特韦预防HIV的男性性交的男性和跨性别女性的HIV感染的扩展分析: HPTN 083

2023-04-1814
OAAI
Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study

在泰国delta和omicron占主导地位期间,异源第三和第四剂量新型冠状病毒肺炎疫苗计划对SARS-CoV-2感染的有效性: 一项测试阴性,病例对照研究

2023-03-0121
OAAI
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
2022-11-1132
OA
Further implications on the global real-world vaccine effectiveness against SARS-CoV-2
2022-08-186
PRE